Register Now - Beyond Recruitment: The Future of Patient Site Engagement in Oncology Clinical Trials
|Articles|May 1, 2012

Applied Clinical Trials

  • Applied Clinical Trials-05-01-2012
  • Volume 21
  • Issue 5

Mentoring New Employees

Author(s)Tim Denman

One increasingly popular way to help ease the transition into a new role in the clinical trial space is through a mentoring program.

As anyone who has started a new job can tell you, those first few days, weeks, or even months can seem like a never ending sea of confusion without a shoreline in sight. One increasingly popular way to help ease the transition into a new role in any industry and especially in the clinical trial space is through a mentoring program.

A successful mentoring program will pair an industry veteran with a company newcomer to help the rookie familiarize him or herself with the company's culture and hopefully build a loyal bond with the organization. Mentoring programs will vary from industry to industry, but one of the tenets of a quality program is the ability to lower turnover and keep the employee happy and productive.

"I think in the clinical trial industry mentoring can really help new employees learn about the partnership between the site that is conducting the research and the sponsor," Deborah Lasher, Clinical Research Specialist at Medtronic said. "That is something you don't learn in school or from a book necessarily.

"The ability to speak to a mentor after a meeting or a site initiation and ask, 'How did I do? How did I come across? Did they understand the training?' That kind of feedback is invaluable."

Mentoring is a two-way street, and often the mentor receives just as much from the pairing as the mentored—beyond the positive feeling that comes from helping a younger colleague gain some valuable industry insight. For example, the younger employee often has a stronger grasp of technology and is able to pass that knowledge onto the mentor in an even exchange of ideas. This two-way street is referred to as reverse mentoring.

The mentoring program at Medtronic has been wildly popular and successful. "On occasion the company has to turn people away simply because they don't have enough mentors," Lasher said. "People realize that it is really an effective way to learn quickly and take advantage of the experience of others and vice versa."

—Timothy Denman

Articles in this issue


Related to this article

Closing the Community Access Gap: Q&A with Kent Thoelke, Paradigm Health
In this Q&A, Kent Thoelke, CEO of Paradigm Health, discusses why participation gaps in community and rural settings come down to both patient cost barriers and site infrastructure, how legacy workflows weigh on community clinics, and what policy and technology changes it would take to make clinical research a real care option for more patients.
© Grispb - © Grispb - stock.adobe.com
Mistral and OpenAI produced identical overall eligibility labels across 200 synthetic patient-study assessments, with criterion-level disagreements concentrated in inclusion criteria where models switch between “Uncertain” and “Not included” when records lack sufficient evidence, so model choice should be driven by deployment architecture, control, and cost rather than assumed interchangeability.
The Human Side of Clinical Trials: Before Burden Becomes Risk, Capturing Friction in Real Time
In Episode 4 of The Human Side of Clinical Trials, host Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., speaks with Jason Riis, PhD, CEO and chief behavioral scientist at Behavioralize, about how capturing friction closer to the moment it happens can reveal unclear instructions, technology friction, and workarounds that retrospective surveys and debriefs tend to miss.